3E Bioventures Capital

3E Bioventures Capital is a healthcare-focused venture capital firm based in Palo Alto, United States, investing across the United States and China. The firm backs frontier life science technologies, with a stated focus on companies developing innovative therapeutic drugs and cross-disciplinary health technologies aimed at healthcare needs not adequately addressed by existing solutions.

Its investment scope spans biotech, TechBio and medical devices. Areas of interest listed by the firm include targeted protein degradation, immuno-oncology, gene therapy, medical imaging, biosensors, ophthalmology, diagnostics and research platforms, alongside therapeutic drug development more broadly. Portfolio activity is oriented towards science-driven healthcare companies across the life sciences, biotechnology, pharmaceuticals, medical devices and diagnostics sectors.

The firm describes its investment philosophy in terms of three elements: expertise, efficiency and execution. Its geographic presence covers Palo Alto and the wider United States market as well as China.